MT1621 | UCB
UCB's Global Corporate Website

MT1621

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Thymidine Kinase 2 (TK2) deficiency An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency Phase 2 MT-1621-102
Ongoing
NCT03845712